|
Dr. Tidwell earned his B.A. degree in Chemistry and Biology at Murray State University and his PhD in Medicinal Chemistry from the University ofTennessee Medical School. He holds a joint appointment as Professor in the Department of Pathology and Laboratory Medicine in the School of Medicine and in the Division of Medicinal Chemistry in the School of Pharmacy at the University of North Carolina at Chapel Hill. He also serves as the Director of the UNC-CH/Gates Foundation Research Consortium and is a
consultant to a number of biotechnology and pharmaceutical companies. The primary focus of Dr. Tidwell’s research is directed toward therapeutics for and the pathogenesis of infectious diseases and structure-activity studies of certain chemicals with regard to blood brain barrier penetration and their effect on physiology and patho-physiology by binding to imidazoline receptors. | 